In vitro biocompatibility analyses of stents coated with diamond-like carbon by flow cytometry, cell growth assays and electron microscopy

Infusionstherapie und Transfusionsmedizin

Volumn 27, Issue 4, 2000, Pages 200-206

  Gutensohn, K ^a   Beythien, C ^a   Koester, R ^a   Bau, J ^a   Fenner, T ^b   Grewe, R ^a   Padmanaban, K ^b   Schaefer, P ^a   Kuehnl, P ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Labor Fenner   (Germany)

Author keywords

Diamond like carbon; Electron microscopy; Flow cytometry; Stent; Thrombogenicity

Indexed keywords

CD63 ANTIGEN; DIAMOND; FIBRINOGEN RECEPTOR; PADGEM PROTEIN; STAINLESS STEEL;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FILM COATING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; STENT; THROMBOGENESIS;

EID: 0033798325     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025268     Document Type: Article

References (39)

1. Bittl JA: Advances in coronary angioplasty. N Engl J Med 1996;335:1290-1302.
2. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706.
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Huevel P: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
4. Fischman DL, Leon MB, Baim DS, Schatz RA, Penn I, Detre K, Savage MP, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish D: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
5. Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N: Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. J Am Coll Cardiol 1997;27:255-261.
6. Currier JW, Faxon DP: Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
7. Mak K, Belli G, Ellis S, Moliterno D: Subacute stent thrombosis: Evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503.
8. Bittl JA: Subacute stent occlusion: Thrombus horribilis. J Am Coll Cardiol 1996;28:368-370.
9. Haycox CL, Ratner BD: In vitro platelet interactions in whole human blood exposed to biomaterial surfaces: Insights in blood compatibility. J Biomed Mater Res 1993;27:1181-1193.
10. Courtney JM, Lamba NMK, Sundaram S, Forbes CD: Biomaterials for blood-contacting applications. Biomaterials 1994;15:737-744.
11. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM: Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
12. Ruygrok P, Serruys P: Intracoronary stenting. From concept to custom. Circulation 1996;94:882-890.
13. Rogers C, Edelmann E: Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001.
14. Bailey SR: Coating of endovascular stents; in Topol E (ed): Textbook of Interventional Cardiology. Philadelphia, Saunders, 1994, pp 754-765.
15. Thomson LA, Law FC, Rushton N, Franks J: Biocompatibility of diamond-like carbon coating. Biomaterials 1991;12:37-40.
16. Tang L, Tsai C, Gerberich WW, Kruckenberg L, Kania DR: Biocompatibility of chemical-vapour-deposited diamond. Biomaterials 1995;16:483-488.
17. Beythien C, Terres W, Hamm CW: In vitro model to test the thrombogenicity of coronary stents. Thromb Res 1994;75:581-590.
18. Ruf A, Patscheke H: Flow cytometric detection of activated platelets: Comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost 1995;21:146-151.
19. Michelson AD: Flow cytometry: A clinical test of platelet function. Blood 1996;87:4925-4936.
20. Köster R, Windsletter U, Überfuhr P, Baumann G, Nikol S, Höfling B: Enhanced migratory activity of vascular smooth muscle cells with high expression of platelet-derived growth factor A and B. Angiology 1995;46:99-106.
21. Ross R: The smooth muscle cell: II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 1971;50:172-186.
22. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunological criteria. J Clin Invest 1973;52:2745-2756.
23. Gutensohn K, Beythien C, Bau J, Meinertz T, Kuehnl P: Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model. Thromb Res 1997;86:49-56.
24. Lu L, Jones M, Wu R: Diamond-like carbon as biological compatible material for cell culture and medical application. Biomed Mater Eng 1993;3: 223-228.
25. Bocchiotti G, Verna G, Fracalvieri M, Fanton E, Datta G, Robotti E: Carbofilm-covered prostheses in plastic surgery: Preliminary observations. Plast Reconstr Surg 1993;91:80-90.
26. Parker T, Perker K, McColl I, Grant D, Wood J: The biocompatibility of low temperature diamond-like carbon films: A transmission electron microscopy, scanning electron microscopy and cytotoxicity study. Diamond Relat Mater 1994;3:1120-1123.
27. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-2801.
28. Shapiro HM (ed): Practical Flow Cytometry, 3rd ed. New York, Wiley-Liss, 1994.
29. Shattil JS, Cunningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood 1987;70: 307-315.
30. Gutensohn K, Kuehnl P: The role of flow cytometry in improving biocompatibility in transfusion medicine. Transfus Sci 1998;19:17-25.
31. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only on activat-ed platelets. J Biol Chem 1984;259:9799-9804.
32. Nieuwenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ: Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987;70:838-845.
33. Ratner BD: The blood compatibility catastrophe. J Biomed Mater Res 1993;27:283-287.
34. Heliums JD, Hardwick RA. Response of platelets to shear stress: A review; in Gross DR, Hwang NHC (eds): The Rheology of Blood, Blood Vessels and Associated Tissues. Alphen aan den Rijn, Sijthoff en Noordhoff, Div. Martinus Nijhoff, 1981, pp 160-183.
35. Ip J, Fuster V, Israel D, Badmin J, Chesebro J: The role of platelets, thrombin, and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:77B-88B.
36. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
37. Grewe PH, Machraoui A, Deneke T, Barmeyer J, Müller KM: Strukturanalyse von 16 verschiedenen Koronarstentsystemen. Z Kardiol 1997;86:990-999.
38. Gawaz M, Neumann FJ, Ott I, May A, Schömig A: Platelet activation and coronary stent implantation: Effect of antithrombolic therapy. Circulation 1996; 94:279-285.
39. Lemaitre D, Barber A, Mullen M: Interventional cardiology: The Cowen Report. 1996.